Derma Sciences, Inc. announces patent granted from Ireland.OLD FORGE, Pa.--(BUSINESS WIRE)--Feb. 7, 1996--DERMA SCIENCES, INC. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : DSCI) (BSE/PSE: DMS) announced today that Ireland has granted patent approval for the Company's Two-Step Procedure for Indolent Wound Healing and the formulations used in conjunction therewith. The patent represents the first nationalized patent in the European Economic Patent Community (EEC EEC: see European Economic Community. ) for the Company. According to John T. Borthwick, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of DERMA der·ma n. See dermis. derma the corium, or true skin. SCIENCES, INC., "The strategic plan for the internationalization of the Company includes expansion into Europe in the near term. The Irish grant follows the grant of the European Patent in 1994." DERMA SCIENCES, INC. is engaged in the development, marketing and sale of primarily proprietary sprays, ointments and dressings for the management of certain chronic non-healing skin ulcerations Ulcerations Breaks in skin or mucous membranes that are often accompanied by loss of tissue on the surface. Mentioned in: Hypersplenism such as pressure and venous ulcers, surgical incisions and burns. The Company markets its products through independent distributors, mainly to health care providers to the geriatric community such as nursing homes, similar extended care facilities, hospitals and health care agencies and managed care providers throughout the United States. In addition, DERMA SCIENCES, INC.'s products are available in selected markets throughout the world through strategic alliances with local companies. CONTACT: JOHN T. BORTHWICK (DSCI) (717) 457-1232 or LEONARDO G. ZANGANI (PR) (908) 788-9660 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion